DCGO241220P3000
- 0.06
- -0.13-68.42%
DocGo Newsroom
DocGo Announces Participation at Three Upcoming Investor Conferences
Do Its Financials Have Any Role To Play In Driving DocGo Inc.'s (NASDAQ:DCGO) Stock Up Recently?
Northland Securities Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $8
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and DocGo (DCGO)
Deutsche Bank Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $5
Q3 2024 DocGo Inc Earnings Call
Needham Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $7
Analysts' Top Healthcare Picks: DocGo (DCGO), Resmed (RMD)
DocGo GAAP EPS of $0.05, Revenue of $138.7M
DocGo Inc. (DCGO) Tops Q3 Earnings Estimates
DocGo Sees FY2025 Sales $410.000M-$450.000M Vs $414.07M Est
DocGo Narrows FY2024 Sales Guidance From $600.00M-650.00M to $620.00M-630.00M VS Est. $619.21M
Express News | DocGo Inc FY2024 Rev View $624.1 Mln -- LSEG IBES Data
10-Q: Q3 2024 Earnings Report
Earnings Flash (DCGO) DOCGO Posts Q3 Revenue $138.7M
Express News | DocGo Q3 Gross Margin 33%
Express News | DocGo Outlook FY Adjusted Ebitda USD 70-75 Million
Express News | DocGo Q3 Net Income USD 4.5 Million Vs. IBES Estimate USD 4.35 Million
Press Release: DocGo Announces Third Quarter 2024 Results
Earnings Preview: DocGo to Report Financial Results Post-market on November 07
$DocGo(DCGO.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $DocGo(DCGO.US)$ to post revenue of USD139.58M for 2024Q3, down 25.18%